STATE STREET CORP - NEUROBO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$8,000
-46.7%
16,5580.0%0.00%
Q1 2022$15,000
-21.1%
16,558
+4.3%
0.00%
Q4 2021$19,000
-67.8%
15,8780.0%0.00%
Q3 2021$59,000
+11.3%
15,8780.0%0.00%
Q2 2021$53,000
-83.7%
15,878
-78.6%
0.00%
Q1 2021$326,000
+34.2%
74,062
+59.8%
0.00%
Q4 2020$243,000
+4.3%
46,357
+11.9%
0.00%
Q3 2020$233,000
-25.1%
41,439
+7.3%
0.00%
Q2 2020$311,00038,6120.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hayden Royal, LLC 20,642$91,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 173,202$762,0000.01%
SG3 Management, LLC 50,000$220,0000.01%
Ameritas Investment Partners, Inc. 378$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,817$43,0000.00%
UBS Group AG 2,841$13,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,926$17,0000.00%
BANK OF AMERICA CORP /DE/ 11,642$51,0000.00%
WELLS FARGO & COMPANY/MN 13,762$61,0000.00%
NORTHERN TRUST CORP 78,993$348,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders